|

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

RECRUITINGN/ASponsored by Duke University
Actively Recruiting
PhaseN/A
SponsorDuke University
Started2025-10-28
Est. completion2027-04-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations6 sites
View on ClinicalTrials.gov →

NCT06906627

Summary

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Screening Program-

Inclusion Criteria:

* Adults with type 2 diabetes (T2D)
* Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP).
* Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR

Exclusion Criteria:

• Chronic kidney disease (CKD) diagnosis

Conditions4

Chronic Kidney Disease(CKD)DiabetesType 2 DMType 2 Diabetes Mellitus (T2DM)

Locations6 sites

University of Alabama
Birmingham, Alabama, 35233
Sarah Machadosmachado@uabmc.edu
Orlando Health
St. Petersburg, Florida, 33701
Timothy Marsh, DO
University of Michigan
Ann Arbor, Michigan, 48109
Angie Westover734-936-6467funke@med.umich.edu
Essentia Health
Duluth, Minnesota, 55805
Haley Messengerhaley.messenger@essentiahealth.org
Duke University
Durham, North Carolina, 27707
Kim Ciciokimberly.cicio@duke.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.